These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36812388)

  • 1. Spatial Distribution of Macrophage Subtypes Among Rejection Subtypes in Renal Transplant Biopsies by Dual Immunohistochemistry.
    Hurdogan O; Karakus F; Dirim AB; Aksu B; Saygili S; Turkmen A; Yilmaz A; Canpolat N; Solakoglu S; Kilicaslan I; Ozluk Y
    Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):224-231. PubMed ID: 36812388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration.
    Buxeda A; Llinàs-Mallol L; Gimeno J; Redondo-Pachón D; Arias-Cabrales C; Burballa C; Puche A; López-Botet M; Yélamos J; Vilches C; Naesens M; Pérez-Sáez MJ; Pascual J; Crespo M
    Am J Transplant; 2023 Apr; 23(4):464-474. PubMed ID: 36710135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the Etiology of Renal Allograft Dysfunction Using Banff 2019 Classification: Correlation with Post-Transplant Duration and Creatinine Levels-A Comprehensive Analysis of 200 Renal Biopsies at a Tertiary Care Medical Center Hospital.
    Saleem R; Nasir H; Chakravarty T; Mansoor I; Alazawi S; Ballouk C; Abdulwaasey M; Shaker N; Sangueza OP; Shaker N
    Int J Surg Pathol; 2024 Oct; ():10668969241283737. PubMed ID: 39360394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Early Complement Activation in Renal Transplantation Associated with Later Graft Outcome?
    Bobka S; Ebert N; Koertvely E; Jacobi J; Wiesener M; Büttner-Herold M; Amann K; Daniel C
    Kidney Blood Press Res; 2018; 43(5):1488-1504. PubMed ID: 30286468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpreting CD56+ and CD163+ infiltrates in early versus late renal transplant biopsies.
    Shin S; Kim YH; Cho YM; Park Y; Han S; Choi BH; Choi JY; Han DJ
    Am J Nephrol; 2015; 41(4-5):362-9. PubMed ID: 26087825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates.
    Gibson IW; Gwinner W; Bröcker V; Sis B; Riopel J; Roberts IS; Scheffner I; Jhangri GS; Mengel M
    Am J Transplant; 2008 Apr; 8(4):819-25. PubMed ID: 18261174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: A new tool to characterize the alloimmune response.
    Calvani J; Terada M; Lesaffre C; Eloudzeri M; Lamarthée B; Burger C; Tinel C; Anglicheau D; Vermorel A; Couzi L; Loupy A; Duong Van Huyen JP; Bruneval P; Rabant M
    Am J Transplant; 2020 Apr; 20(4):942-953. PubMed ID: 31715060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Subphenotypes of Antibody-Mediated Rejection in Kidney Transplants.
    Halloran PF; Merino Lopez M; Barreto Pereira A
    Am J Transplant; 2016 Mar; 16(3):908-20. PubMed ID: 26743766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations.
    Haas M
    Am J Transplant; 2016 May; 16(5):1352-7. PubMed ID: 26696524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between pathologic lesions of active and chronic antibody-mediated rejection in renal allografts.
    Haas M
    Am J Transplant; 2018 Dec; 18(12):2849-2856. PubMed ID: 30133953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Glomerular C4d and Morphologic Glomerular Lesions as a Possible Indicator in the Diagnosis of Acute or Chronic Active Antibody-Mediated Rejection.
    Lee YJ; Lee JH; Jung CW; Gwon JG; Ko SY; Lee J; Jo SK; Cho WY; Kim MG
    Transplant Proc; 2019 Oct; 51(8):2660-2666. PubMed ID: 31445765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Macrophage Polarization in Antibody-Mediated Rejection of Renal Allograft.
    Kim J; Choi SE; Lim BJ; Kim YS; Huh KH; Lee J; Kim SI; Kim MS; Jeong HJ
    Transplant Proc; 2018 May; 50(4):1005-1008. PubMed ID: 29731056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction.
    Gimeno J; Redondo D; Pérez-Sáez MJ; Naranjo-Hans D; Pascual J; Crespo M
    Nephrol Dial Transplant; 2016 Nov; 31(11):1938-1946. PubMed ID: 27312147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term kidney allograft survival in patients with transplant glomerulitis.
    Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
    Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of Revised Banff Criteria in the Diagnosis of Antibody-Mediated Rejection.
    Jeong HS; Kim DG; Lee ST; Huh KH; Kim YS; Jeong HJ; Lim BJ
    Transplant Proc; 2019 Jun; 51(5):1488-1490. PubMed ID: 31053345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial activation, lymphangiogenesis, and humoral rejection of kidney transplants.
    Phillips S; Kapp M; Crowe D; Garces J; Fogo AB; Giannico GA
    Hum Pathol; 2016 May; 51():86-95. PubMed ID: 27067786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
    Solar-Cafaggi D; Marino L; Uribe-Uribe N; Morales-Buenrostro LE
    Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.